Passing this one big raise and huge valuation considering FDA approval is some time away. Nothing for IPO investor to gain seems fully valued at IPO valuation if not over valued.
At least company won't need money for few years to come with such a huge raise
- Forums
- IPOs
- EBR systems
EBR systems, page-18
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)